Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography
- 18 October 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 783 (2) , 491-500
- https://doi.org/10.1016/s1570-0232(02)00728-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Therapeutic Drug Monitoring of HIV Protease Inhibitors Using High-Performance Liquid Chromatography With Ultraviolet or Photodiode Array DetectionTherapeutic Drug Monitoring, 2001
- Standard methods to measure HIV drug concentrationsThe Lancet, 2001
- The 2nd International Workshop on Clinical Pharmacology of HIV TherapyExpert Opinion on Pharmacotherapy, 2001
- High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid–liquid extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsAIDS, 2001
- Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral DosingAntimicrobial Agents and Chemotherapy, 2001
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple TherapyAntiviral Therapy, 1998
- Approved recommendation (1978) on quality control in clinical chemistryClinica Chimica Acta; International Journal of Clinical Chemistry, 1979